115 related articles for article (PubMed ID: 1495013)
1. N-methylated analogs of Ac[Nle28,31]CCK(26-33): synthesis, activity, and receptor selectivity.
Ron D; Gilon C; Hanani M; Vromen A; Selinger Z; Chorev M
J Med Chem; 1992 Jul; 35(15):2806-11. PubMed ID: 1495013
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological studies on CCKB receptors in guinea pig synaptoneurosomes.
Galas MC; Bernad N; Martinez J
Eur J Pharmacol; 1992 May; 226(1):35-41. PubMed ID: 1327841
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of N alpha-hydroxysulfonyl-[Nle28,31]-CCK26-33.
Sugg EE; Shook JE; Serra M; Korc M; Yamamura HI; Burks TF; Hruby VJ
Life Sci; 1986 Nov; 39(18):1623-9. PubMed ID: 2430160
[TBL] [Abstract][Full Text] [Related]
4. Correlation between phospholipid breakdown, intracellular calcium mobilization and enzyme secretion in rat pancreatic acini treated with Boc-[Nle28, Nle31]-CCK-7 and JMV180, two cholecystokinin analogues.
Lignon MF; Galas MC; Rodriguez M; Martinez J
Cell Signal; 1990; 2(4):339-46. PubMed ID: 1701321
[TBL] [Abstract][Full Text] [Related]
5. Full agonists of CCK8 containing a nonhydrolyzable sulfated tyrosine residue.
Marseigne I; Roy P; Dor A; Durieux C; Pélaprat D; Reibaud M; Blanchard JC; Roques BP
J Med Chem; 1989 Feb; 32(2):445-9. PubMed ID: 2464062
[TBL] [Abstract][Full Text] [Related]
6. A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity.
Knapp RJ; Vaughn LK; Fang SN; Bogert CL; Yamamura MS; Hruby VJ; Yamamura HI
J Pharmacol Exp Ther; 1990 Dec; 255(3):1278-86. PubMed ID: 2262906
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity studies of C- and N-terminal fragments of cholecystokinin 26-33 in guinea pig isolated tissues.
Gaudreau P; St-Pierre S; Pert CB; Quirion R
Neuropeptides; 1987 Jul; 10(1):9-18. PubMed ID: 3670570
[TBL] [Abstract][Full Text] [Related]
8. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.
Durieux C; Ruiz-Gayo M; Corringer PJ; Bergeron F; Ducos B; Roques BP
Mol Pharmacol; 1992 Jun; 41(6):1089-95. PubMed ID: 1614411
[TBL] [Abstract][Full Text] [Related]
9. Replacement of Tyr-SO3H by a p-carboxymethyl-phenylalanine in a CCK8-derivative preserves its high affinity for CCK-B receptor.
McCort-Tranchepain I; Ficheux D; Durieux C; Roques BP
Int J Pept Protein Res; 1992 Jan; 39(1):48-57. PubMed ID: 1378822
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activity of Boc [Nle28, Nle31]CCK27-33, a highly potent CCK8 analogue.
Ruiz-Gayo M; Daugé V; Menant I; Bégué D; Gacel G; Roques BP
Peptides; 1985; 6(3):415-20. PubMed ID: 2415950
[TBL] [Abstract][Full Text] [Related]
11. Models for the A- and B-receptor-bound conformations of CCK-8.
Nikiforovich GV; Hruby VJ
Biochem Biophys Res Commun; 1993 Jul; 194(1):9-16. PubMed ID: 8333874
[TBL] [Abstract][Full Text] [Related]
12. Boc-Trp-Orn(Z)-Asp-NH2 and derivatives: a new family of CCK antagonists.
Gonzalez-Muniz R; Bergeron F; Marseigne I; Durieux C; Roques BP
J Med Chem; 1990 Dec; 33(12):3199-204. PubMed ID: 1701834
[TBL] [Abstract][Full Text] [Related]
13. CCK-B agonist or antagonist activities of structurally hindered and peptidase-resistant Boc-CCK4 derivatives.
Corringer PJ; Weng JH; Ducos B; Durieux C; Boudeau P; Bohme A; Roques BP
J Med Chem; 1993 Jan; 36(1):166-72. PubMed ID: 8421283
[TBL] [Abstract][Full Text] [Related]
14. A71378: a CCK agonist with high potency and selectivity for CCK-A receptors.
Lin CW; Holladay MW; Witte DG; Miller TR; Wolfram CA; Bianchi BR; Bennett MJ; Nadzan AM
Am J Physiol; 1990 Apr; 258(4 Pt 1):G648-51. PubMed ID: 2333977
[TBL] [Abstract][Full Text] [Related]
15. Large and prolonged in vivo response of pancreatic secretion to phenylethylamide and phenylethylester derivatives of Boc-[Nle28-Nle31]CCK(26-33) in the rat.
Nagain C; Lignon MF; Galas MC; Rodriguez M; Martinez J; Rozé C
Peptides; 1992; 13(6):1127-32. PubMed ID: 1494494
[TBL] [Abstract][Full Text] [Related]
16. Binding of cholecystokinin-8 (CCK-8) peptide derivatives to CCKA and CCKB receptors.
Schäfer U; Harhammer R; Boomgaarden M; Sohr R; Ott T; Henklein P; Repke H
J Neurochem; 1994 Apr; 62(4):1426-31. PubMed ID: 8133271
[TBL] [Abstract][Full Text] [Related]
17. Cholecystokinin analogues with high affinity and selectivity for brain membrane receptors.
Hruby VJ; Fang SA; Knapp R; Kazmierski W; Lui GK; Yamamura HI
Int J Pept Protein Res; 1990 Jun; 35(6):566-73. PubMed ID: 2401597
[TBL] [Abstract][Full Text] [Related]
18. Identification of CCK-A receptors on chief cells with use of a novel, highly selective ligand.
Pradhan TK; Qian JM; Sutliff VE; Mantey SA; Jensen RT
Am J Physiol; 1995 Apr; 268(4 Pt 1):G605-12. PubMed ID: 7733286
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological activity of novel, potent and long-acting analogs of AC-CCK-7 with high affinity for peripheral (type A) receptors.
Danho W; Makofske RC; Swistok J; Michalewsky J; Gabriel T; Marks N; Berg MJ; Baird L; Geiler V; Mackie G
Pept Res; 1991; 4(2):59-65. PubMed ID: 1815779
[TBL] [Abstract][Full Text] [Related]
20. Suc-Tyr(SE)-Met-Gly-Trp-Met-Asp-beta-phenethylamide(410): a competitive antagonist of cholecystokinin-induced contractions in smooth muscles in vitro.
Rakovska A; Henklein P; Milenov K; Nieber K; Oehme P
Methods Find Exp Clin Pharmacol; 1987 Jul; 9(7):429-35. PubMed ID: 3683016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
